Research Article
Investigation of the Vitamin D Receptor Polymorphisms in Acromegaly Patients
Table 1
Demographic characteristics of acromegaly patients and control group.
| | Acromegaly () | Control () |
| Gender (, %) | | | Female | 31 (59.6) | 53 (63.9) | Male | 21 (40.4) | 30 (36.1) | Age (y) | 45.7 ± 1.9 | 43.1 ± 2.6 | Age onset (y) | 39.5 ± 1.9 | | Tumor size before treatment (, %) | | | Macroadenoma | 36 (81.8) | | Microadenoma | 8 (18.2) | | Number of resection (, %) | | | 0 | 8 (17.8) | | 1 | 29 (64.4) | | 2 | 8 (17.8) | | IGF1 (ng/mL) | | | Before treatment | 882.5 ± 56 | | After treatment | 234.6 ± 21.3 | | IGF1 (% ULN) | | | Before treatment | 330.0 ± 21 | | After treatment | 100.8 ± 10.4 | | GH (ng/mL) | | | Before treatment | 18.3 ± 2.9 | | After treatment | 1.3 ± 0.2 | | Remission status (, %) | | | Controlled | 36 (80) | | Uncontrolled | 9 (20) | | Tumor size after treatment (, %) | | | ≥1 cm | 10 (22.7) | | <1 cm | 34 (77.3) | | 25(OH)D3 (nmol/L)* | 5.5 ± 1.1 | 29.9 ± 2.1 |
|
|
Data are shown as mean ± standard error. IGF1 (%ULN): IGF1/upper limit of normal (age-matched) 100. *.
|